Stocks
Heron Therapeutics (HRTX) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -208.7 | -228.2 | -217.8 | -174.7 | -107.7 | -43.6 | ||
| Changes by years, y/y, % | +13% | +9% | -5% | -20% | -38% | -10.1% | |||
Heron Therapeutics. EBITDA US GAAP, bln rub
Heron Therapeutics. EBITDA US GAAP, changes, %
Heron Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Heron Therapeutics (HRTX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -41.7 | -24.2 | -9.51 | -4.11 | -5.80 | -43.6 | |
| Changes by years, y/y, % | -15% | -41% | -53% | -87% | -86% | |||
| Changes by quarters, q/q, % | +29% | -42% | -61% | -57% | +41% | |||
